Leaps by Bayer Overview
Founded in 2015, Leaps by Bayer is the impact investment arm of Bayer AG, dedicated to making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity. The firm specializes in the fields of biotechnology, agriculture, and scientific breakthroughs, aiming to address some of the world's biggest challenges in health and agriculture.
Is Leaps by Bayer the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Leaps by Bayer, along with a list of other relevant VCs, is available on Hopohopo.io.
Leaps by Bayer
Investment focus
Invest in
- Western Europe 1 / 14
- North America 2 / 5
Product type
- Software
- Drugs / Pharma
- Other
Industries / verticals
- AgriTech / FoodTech
- BioTech & Life Sciences
Stages
Pre-seed, Seed, Series A, Series B or later
First ticket size
€100,000 - €1,500,000
How to approach funds like Leaps by Bayer
When engaging Leaps by Bayer, founders should highlight how their technology or solution represents a transformative leap rather than an incremental improvement, especially in areas with high unmet needs. Demonstrate a clear path to large-scale impact and articulate how your vision aligns with solving global challenges in health or agriculture. Emphasize robust scientific validation, a credible roadmap to regulatory milestones, and the potential for broad societal benefit, as Leaps by Bayer seeks bold, paradigm-shifting innovations.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
